Longterm Results 60 Months after LDR-Brachytherapy +-EBRT+-ADT for Non-Metastasized Prostate Cancer with Low, Intermediate and High Progression Risk - Evaluation for Various Risk Group Systems, I-PSA, I-Gleason and I-Stage